GlassScriptPhysician profile
Paul D Kelsey
NPI 1194048272
$1,206.03
in general payments reported to CMS, 2019-2025
11 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $116 · 2021: $375 · 2022: $142 · 2023: $129 · 2024: $120 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $444.97 | 2020-2025 | Exparel, Iovera, Zilretta |
| Avanos Medical | $293.73 | 2019-2023 | Pnb and Accessories |
| Merck Sharp & Dohme LLC | $192.58 | 2019-2025 | Bridion |
| Medtronic, INC. | $62.17 | 2022-2025 | Corevalve Evolut R |
| Mallinckrodt Enterprises LLC | $51.14 | 2019 | |
| Mallinckrodt Hospital Products INC. | $36.23 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $34.58 | 2025 | |
| Eagle Pharmaceuticals, INC. | $25.00 | 2024 | |
| Stryker Corporation | $24.14 | 2023 | Na, Stryker Varispeed |
| Covidien LP | $21.39 | 2019 | |
| Atricure, INC. | $20.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kelsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.